S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)

Seelos Therapeutics (SEEL) News Today

$1.39
-0.06 (-4.14%)
(As of 12/29/2023 ET)
SourceHeadline
finance.yahoo.com logoSeelos Therapeutics, Inc. Releases Letter to its Stockholders
finance.yahoo.com - December 22 at 9:07 AM
finance.yahoo.com logo11 Most Promising Psychedelic Stocks According to Hedge Funds
finance.yahoo.com - December 20 at 3:30 PM
msn.com logoSeelos Therapeutics files for $250M mixed shelf
msn.com - December 18 at 8:02 PM
msn.com logoSeelos Therapeutics (SEEL) Price Target Increased by 2900.00% to 122.40
msn.com - December 16 at 3:27 PM
finance.yahoo.com logoInsider Spends US$100k Buying More Shares In Seelos Therapeutics
finance.yahoo.com - December 4 at 8:19 AM
finance.yahoo.com logoInsider Buying: CFO Michael Golembiewski Acquires 83,000 Shares of Seelos Therapeutics Inc (SEEL)
finance.yahoo.com - December 2 at 8:16 AM
finance.yahoo.com logoSeelos Therapeutics Announces Closing of Public Offering
finance.yahoo.com - December 1 at 8:21 PM
benzinga.com logoThinking about buying stock in Neximmune, ShiftPixy, Ampio Pharmaceuticals, Seelos Therapeutics, or Nio Inc?
benzinga.com - December 1 at 10:20 AM
benzinga.com logoThinking about buying stock in RedHill Biopharma, Mynaric, Energy Transfer LP, Seelos Therapeutics, or Petco Health and Wellness?
benzinga.com - November 29 at 10:25 AM
marketwatch.com logoSeelos Therapeutics Shares Slide Premarket After Public Offering
marketwatch.com - November 29 at 10:25 AM
investorplace.com logoWhy Is Seelos Therapeutics (SEEL) Stock Down 42% Today?
investorplace.com - November 29 at 10:02 AM
markets.businessinsider.com logoSeelos Therapeutics Announces Pricing Of $5.55 Mln Public Offering; Stock Drops
markets.businessinsider.com - November 28 at 11:37 PM
msn.com logoSeelos Therapeutics commences a public offering of its shares
msn.com - November 28 at 6:37 PM
finance.yahoo.com logoSeelos Therapeutics Announces Proposed Public Offering
finance.yahoo.com - November 28 at 6:37 PM
msn.com logoSeelos stock falls 23% following 1-for-30 reverse split
msn.com - November 28 at 1:36 PM
msn.com logoSeelos Therapeutics, Iterum Therapeutics among healthcare movers
msn.com - November 28 at 1:36 PM
marketbeat.com logo
marketbeat.com - November 28 at 6:05 AM
msn.com logoDefense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans
msn.com - November 27 at 5:33 PM
markets.businessinsider.com logoSeelos' SLS-002 To Be Included In DOD's Trial To Evaluate Potential Treatments For PTSD
markets.businessinsider.com - November 27 at 9:08 AM
finance.yahoo.com logoSeelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)
finance.yahoo.com - November 27 at 9:08 AM
marketwatch.com logoSeelos to Implement 1-for-30 Reverse Stock Split
marketwatch.com - November 24 at 1:42 PM
benzinga.com logoWhy Seelos Therapeutics Shares Are Diving Today
benzinga.com - November 24 at 1:42 PM
finance.yahoo.com logoSeelos Therapeutics Announces 1-for-30 Reverse Stock Split
finance.yahoo.com - November 24 at 1:42 PM
msn.com logoDole (DOLE) Q3 Earnings Top Estimates
msn.com - November 16 at 12:14 PM
msn.com logoSeelos Therapeutics (SEEL) Price Target Increased by 60.00% to 4.08
msn.com - November 1 at 2:30 PM
finance.yahoo.com logoSeelos Therapeutics to Present a Poster on SLS-005 in Alzheimer's Disease at Neuroscience 2023
finance.yahoo.com - October 27 at 12:45 PM
finance.yahoo.com logoSeelos Therapeutics Retains Canaccord Genuity in Connection with Review of Potential Partnerships and Collaborations
finance.yahoo.com - October 17 at 10:22 AM
finance.yahoo.com logoEmpery Alleges Critical Clinical Trial Misrepresentations by Seelos Therapeutics
finance.yahoo.com - October 10 at 2:25 PM
msn.com logoSeelos Therapeutics' Aggressive Alzheimer's Hopeful Candidate Shows Encouraging Preclinical Activity
msn.com - September 27 at 11:01 PM
markets.businessinsider.com logoSeelos Announces Encouraging Data From Study Of SLS-005 In Preclinical Model Of Alzheimer's Disease
markets.businessinsider.com - September 27 at 12:59 PM
finance.yahoo.com logoSeelos Therapeutics Announces Encouraging Data from an In Vivo Study of SLS-005 in an Aggressive Preclinical Model of Alzheimer's Disease
finance.yahoo.com - September 27 at 12:59 PM
msn.com logoGuggenheim Downgrades Seelos Therapeutics (SEEL)
msn.com - September 23 at 7:50 AM
marketwatch.com logoSeelos Therapeutics Hits Another New Low After Stock Sale >SEEL
marketwatch.com - September 22 at 7:52 PM
nasdaq.com logoBenchmark Maintains Seelos Therapeutics (SEEL) Speculative Buy Recommendation
nasdaq.com - September 22 at 7:52 PM
markets.businessinsider.com logoWhere Seelos Therapeutics Stands With Analysts
markets.businessinsider.com - September 22 at 2:52 PM
investorplace.com logoWhy Is Seelos Therapeutics (SEEL) Stock Down 25% Today?
investorplace.com - September 21 at 1:02 PM
marketwatch.com logoSeelos Therapeutics Shares Slide Premarket on SLS-002 Study Shortfall >SEEL
marketwatch.com - September 20 at 7:43 PM
msn.com logoWhy Is Depression Focused Seelos Therapeutics Stock Plunging Today?
msn.com - September 20 at 2:43 PM
marketwatch.com logoSeelos Therapeutics Shares Plumb New Depths on Study Shortfall >SEEL
marketwatch.com - September 20 at 2:43 PM
msn.com logoUS Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision
msn.com - September 20 at 9:42 AM
msn.com logoSeelos Therapeutics’ stock slides 36% after trial of treatment for suicidal ideation has too few patients to meet endpoint
msn.com - September 20 at 9:42 AM
markets.businessinsider.com logoSeelos Therapeutics: SLS-002 Phase II Study Fails To Meet Primary Endpoint On Limited Sample Size
markets.businessinsider.com - September 20 at 9:42 AM
proactiveinvestors.com logoSeelos tumbles 66% as depression drug fails after it recruits too few patients
proactiveinvestors.com - September 20 at 9:42 AM
finance.yahoo.com logoSeelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide
finance.yahoo.com - September 20 at 9:42 AM
finance.yahoo.com logo7 Biotech Stocks to Sell in September Before They Crash & Burn
finance.yahoo.com - September 14 at 10:37 AM
markets.businessinsider.com logo4 Analysts Have This to Say About Seelos Therapeutics
markets.businessinsider.com - August 22 at 6:27 PM
marketbeat.com logoMAI Capital Management Has $641,000 Stock Holdings in Seelos Therapeutics, Inc. (NASDAQ:SEEL)
marketbeat.com - August 22 at 6:41 AM
marketbeat.com logoMirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in Seelos Therapeutics, Inc. (NASDAQ:SEEL)
marketbeat.com - August 18 at 4:24 AM
msn.com logoCantor Fitzgerald Reiterates Seelos Therapeutics (SEEL) Overweight Recommendation
msn.com - August 16 at 2:25 AM
finance.yahoo.com logoSeelos Therapeutics Provides Second Quarter 2023 Clinical Update
finance.yahoo.com - August 14 at 6:03 PM
Get Seelos Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SEEL and its competitors with MarketBeat's FREE daily newsletter.



SEEL Media Mentions By Week

SEEL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SEEL
News Sentiment

1.87

0.84

Average
Medical
News Sentiment

SEEL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SEEL Articles
This Week

1

2

SEEL Articles
Average Week

Get Seelos Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SEEL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:SEEL) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -